Upload
Featured Recent Articles Topics Login Upload

Search Results for 'hiv cd4'

hiv cd4 published presentations and documents on DocSlides.

Ibalizumab ( Trogarzo ) Prepared by:
Ibalizumab ( Trogarzo ) Prepared by:
by audrey
Brian R. Wood, MD. David Spach, MD. Last Updated: ...
Perspectives from MSF’s AHD programmes in Africa:
Perspectives from MSF’s AHD programmes in Africa:
by alyssa
Challenges, lessons, and opportunities. Tom Ellman...
CUTANEOUS MANIFESTATIONS OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION
CUTANEOUS MANIFESTATIONS OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION
by kylie
BY. DR. JAHNABI. MODERATOR. DR. BHASKAR GUPTA, PR...
Human Immunodeficiency Virus Part II
Human Immunodeficiency Virus Part II
by iris
Catherine . Czesnowski. MD.. PYG 1 IM. Pathogenes...
Enhancing Benefits of Early Antiretroviral
Enhancing Benefits of Early Antiretroviral
by blastoracle
Therapy. Evidence, Implication and Preliminary Fin...
New Directions in the future 2015
New Directions in the future 2015
by mitsue-stanley
Consolidated ARV Guidelines Update. Meg . Doherty...
Charles B. Hicks, MD Professor of Medicine
Charles B. Hicks, MD Professor of Medicine
by karlyn-bohler
Duke University Medical Center. Durham, North Car...
Table ronde Comorbidités
Table ronde Comorbidités
by tatyana-admore
Immunologie et VIH. Impact de la PREP . sur. la ...
Lecture 9-A Infectious
Lecture 9-A Infectious
by pamella-moone
Diseases. “Human Immunodeficiency Virus. Infect...
The impact of a limited subsidy on access to antiretroviral therapy (ART) and patient outcomes in S
The impact of a limited subsidy on access to antiretroviral therapy (ART) and patient outcomes in S
by celsa-spraggs
Barnaby Young. Infectious Diseases registrar. Com...
VIROTEAM 10-12 Septembre2015
VIROTEAM 10-12 Septembre2015
by ellena-manuel
Marseille. HIV-1–specific T-cell responses in e...
New Directions in the 2015 Consolidated ARV Guidelines Update
New Directions in the 2015 Consolidated ARV Guidelines Update
by test
Meg . Doherty, MD, PhD, MPH. 19 July 2015. WHO Sa...
ART in Resource-limited settings :
ART in Resource-limited settings :
by liane-varnes
Progress and Challenges. Dr. B. B. . Rewari. MD,...
HIV Care Continuum New Diagnoses
HIV Care Continuum New Diagnoses
by yoshiko-marsland
, . Georgia, . 2011 . Persons . with HIV . Engage...
HIV Care Continuum New Diagnoses, 2011, Atlanta Eligible Metropolitan Area (EMA)
HIV Care Continuum New Diagnoses, 2011, Atlanta Eligible Metropolitan Area (EMA)
by debby-jeon
Persons . with HIV . Engaged . in S. elected . S....
Viral and Host characteristics of a child with perinatal HIV-1 after prolonged period of ART cessat
Viral and Host characteristics of a child with perinatal HIV-1 after prolonged period of ART cessat
by tawny-fly
Avy . Violari, . Mark . Cotton, . Louise . Kuhn, ...
Georgia HIV Care Continuum Update:
Georgia HIV Care Continuum Update:
by test
Persons Living with HIV. , 2016, and Persons Diag...
Michael S. Saag , MD Eric S.
Michael S. Saag , MD Eric S.
by pamella-moone
Daar. , MD. Antiretroviral Therapy:. A Case-Based...
High Rates of Tuberculosis in Patients Accessing HAART in R
High Rates of Tuberculosis in Patients Accessing HAART in R
by luanne-stotts
Kogieleum. . Naidoo . on behalf of. . Quarraish...
Hepatitis B Case Studies
Hepatitis B Case Studies
by alida-meadow
Nina Kim, MD MSc. Associate Professor of Medicine...
ART Initiation in Resource-Limited Settings
ART Initiation in Resource-Limited Settings
by lois-ondreau
Susan M. Graham . Assistant Professor, Medicine a...
HUMAN IMMUNODEFICIENCY VIRUS DISEASE
HUMAN IMMUNODEFICIENCY VIRUS DISEASE
by marina-yarberry
BY: Dr. . Sha`bani. . AIDS first recognized in t...
Ctrl
Ctrl
by phoebe-click
siRNA. + p21siRNA. a. b. c. p21. β-actin. Figure...
South Africa’s
South Africa’s
by marina-yarberry
experiences and future plans for CD4 and viral lo...
Should we treat
Should we treat
by trish-goza
HIV Controllers ?. IAS 2013. Pr Olivier Lambotte....
Hepatitis B Case Studies
Hepatitis B Case Studies
by yoshiko-marsland
Nina Kim, MD MSc. Associate Professor of Medicine...
Memory CCR6+CD4+ T-Cells are Selectively Imprinted with a T
Memory CCR6+CD4+ T-Cells are Selectively Imprinted with a T
by trish-goza
. Patricia Monteiro, Jean-Philippe Goulet, . Ann...
Late Presentation
Late Presentation
by min-jolicoeur
of HIV Infection. James Hand. Clinical Nurse Mana...
Supplemental Digital Content 5 -
Supplemental Digital Content 5 -
by test
Figure 1. . CD4. HIV-2 subgroup and control . h...
Paul Allyn, MD
Paul Allyn, MD
by conchita-marotz
African American HIV University. University of Ca...
Pediatric HIV Treatment Landscape - Africa
Pediatric HIV Treatment Landscape - Africa
by white
Family Clinical Trial Unit. Tygerberg Children’s...
HIV OI's and prophylaxis
HIV OI's and prophylaxis
by callie
, PEP, PREP . Compiled by Jason Vermaak, . Ektha. ...
Impact of CMV on HIV Outcomes
Impact of CMV on HIV Outcomes
by roxanne
Peter W. . Hunt. , MD. Division . of. Experimenta...
Virologic and Immunologic Monitoring in HIV Care
Virologic and Immunologic Monitoring in HIV Care
by sylvia
and. HIV Resistance Assays. www.hivguidelines.org....
INITIAL MANAGEMENT OF THE PATIENT LIVING WITH HIV
INITIAL MANAGEMENT OF THE PATIENT LIVING WITH HIV
by edolie
PART 3. INITIATING THERAPY. Objectives. After comp...
CHIDAMIDE DISRUPTS AND REDUCES HIV-1 LATENCY IN PATIENTS ON SUPPRESSIVE ANTIRETROVIRAL THERAPY
CHIDAMIDE DISRUPTS AND REDUCES HIV-1 LATENCY IN PATIENTS ON SUPPRESSIVE ANTIRETROVIRAL THERAPY
by sophie
Y. . S. un, J. Li, J. Ma, C. Wang, F. Bai, K. Zhao...
HIV/AIDS For Physiotherapy 3
HIV/AIDS For Physiotherapy 3
by lucinda
rd. year student . Department of physiotherapy. N...
Probability of AIDS and non-AIDS-related mortality of early-treated children living with HIV-1
Probability of AIDS and non-AIDS-related mortality of early-treated children living with HIV-1
by bella
C. . Bréhin.  ,  A. Tagarro ,  S. Domíngue...
CROI 2015: Hot Topics in HIV Primary Care
CROI 2015: Hot Topics in HIV Primary Care
by dora
Brian R. Wood, MD. Assistant Professor of Medicine...
HIV Testing <Presenter, date>
HIV Testing <Presenter, date>
by violet
Co-funded . by the 2. nd. Health Programme of the...